Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer

Clinical trial NCT04301414 · COMPLETED

Trial details

NCT number: NCT04301414
Sponsor: Columbia University
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2020-02-25
Primary completion: 2025-03-13
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.